USE OF EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) TARGETING AGENTS IN TREATING LUNG DISORDERS
Switzerland
19723298.6
Filed on 2019-04-30
19723298.6
Filed on 2019-04-30
USE OF EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) TARGETING AGENTS IN TREATING LUNG DISORDERS
United Kingdom
19723298.6
Filed on 2019-04-30
19723298.6
Filed on 2019-04-30
USE OF EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) TARGETING AGENTS IN TREATING LUNG DISORDERS
Germany
19723298.6
Filed on 2019-04-30
19723298.6
Filed on 2019-04-30
USE OF EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) TARGETING AGENTS IN TREATING LUNG DISORDERS
France
19723298.6
Filed on 2019-04-30
19723298.6
Filed on 2019-04-30
MUTANT ARA H 2 AND ARA H 6 PROTEINS AND USES THEREOF
Patent Cooperation Treaty
PCT/US2024/017072
Filed on 2024-02-23
PCT/US2024/017072
Filed on 2024-02-23
Massively Paralleled Multi-patient Assay For Pathogenic Infection Diagnosis And Host Physiology Surveillance Using Nucleic Acid Sequencing
US Application 18/031,165
Filed on 2023-04-11
Filed on 2023-04-11
Massively Paralleled Multi-patient Assay For Pathogenic Infection Diagnosis And Host Physiology Surveillance Using Nucleic Acid Sequencing
Patent Cooperation Treaty
PCT/US21/59996
Filed on 2021-11-19
PCT/US21/59996
Filed on 2021-11-19
USE OF EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) TARGETING AGENTS IN TREATING LUNG DISORDERS
China
201980029352.0
Filed on 2019-04-30
201980029352.0
Filed on 2019-04-30
USE OF EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) TARGETING AGENTS IN TREATING LUNG DISORDERS
Israel
278246
Filed on 2020-10-22
278246
Filed on 2020-10-22